COMPANIES COVERED
Bausch HealthDownload FREE Report Sample
Download Free sampleIrritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.
Irritable Bowel Syndrome Treatment Market contains market size and forecasts of Irritable Bowel Syndrome Treatment in Global, including the following market information:
Global Irritable Bowel Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Irritable Bowel Syndrome Treatment market was valued at 1947 million in 2021 and is projected to reach US$ 2582 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Irritable Bowel Syndrome with Constipation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Irritable Bowel Syndrome Treatment include Bausch Health, Sucampo Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Salix Pharmaceuticals, Ironwood Pharmaceuticals, GlaxoSmithKline and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Irritable Bowel Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Irritable Bowel Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Global Irritable Bowel Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Irritable Bowel Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Homecare Settings
Global Irritable Bowel Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Irritable Bowel Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Irritable Bowel Syndrome Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Sucampo Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals
Salix Pharmaceuticals
Ironwood Pharmaceuticals
GlaxoSmithKline
Allergan
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy